David is co-founder and chairperson of Refactor. Most recently, David was the Managing Partner at SV Angel, which invested in Coinbase, Flatiron Health (acq. by Roche), Chain.com, Blockstack, Doordash, Stripe, Airbnb, Slack, Climate (acq. by Monsanto), Dropbox, and many others during his tenure. 
Follow him on Twitter: <a href="https://twitter.com/davidlee">https://twitter.com/davidlee</a>

David is co-founder and chairperson of Refactor. Most recently, David was the Managing Partner at SV Angel, which invested in Coinbase, Flatiron Health (acq. by Roche), Chain.com, Blockstack, Doordash, Stripe, Airbnb, Slack, Climate (acq. by Monsanto), Dropbox, and many others during his tenure. Follow him on Twitter: https://twitter.com/davidlee

David is co-founder and chairperson of Refactor. Most recently, David was the Managing Partner at SV Angel, which invested in Coinbase, Flatiron Health (acq. by Roche), Chain.com, Blockstack, Doordash, Stripe, Airbnb, Slack, Climate (acq. by Monsanto), Dropbox, and many others during his tenure.&nbsp;
Follow him on Twitter: <a href="https://twitter.com/davidlee" rel="noopener noreferrer">https://twitter.com/davidlee</a>

Ep. 16 - David Lee

A podcast about drug culture, policy, and business with an emphasis on harm reduction. We believe that prohibition and abstinence only policies result in poor results for society. We’ll be discussing how drugs are sold and perhaps more importantly, how they should be sold. This is not intended to advocate drug use and meant for educational purposes only.

Share Ep. 16 - David Lee

Sign up to save your podcasts

Ep. 16 - David Lee

Ep. 16 - David Lee